Deck Bio
PrivateLast Round
Seed
Apr 9, 2026
Total Funding Raised
$3.1M
Company Overview
Deck Bio is a biotechnology company developing T cell engagers that recognize multiple cancer signals to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deck Bio Comps
Public and private peers based on sector, stage, and business model.
Deck Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 9, 2026 |
Deck Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BrightEdge | Seed |
| Mission BioCapital | Seed |
| Impact Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
$3.1M round with Mission BioCapital and BrightEdge
Deck Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Deck Bio's valuation, stock price, and market status.
